Skip to content

ARCH THERAPEUTICS, INC.

CIK 0001537561

← back to feed
Revenue (TTM)
$121.94K
+383.8% YoY Q3 Aug 2024
Net Income (TTM)
−$11.63M
−32.4% YoY Q3 Aug 2024
EPS Diluted (TTM)
−$2.86
−50.0% YoY Q3 Aug 2024
Gross Margin
0.0%
Q3 Aug 2024
Operating Margin
-3,614.3%
Q3 Aug 2024
Net Margin
-9,536.4%
Q3 Aug 2024
Free Cash Flow (TTM)
−$3.83M
Q3 Aug 2024
Cash
$1.96M
Q3 Aug 2024
Total Debt
$0
Q3 Aug 2024
Shares Outstanding
4.44M sh
Q3 Aug 2024

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings